Splenic embolization for a giant splenic hemangioma in a child: a case report

• Published in: BMC pediatrics Vol. 18; no. 1; p. 354
• Main Authors: Choi, Woosun, Choi, Young Bae
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 12.11.2018; BioMed Central; BMC
• Subjects: Abdomen; Analgesics; Analysis; Blood pressure; Care and treatment; Case Report; Case reports; Child; Child health; Children & youth; Embolization; Hemangioma; Immunization; Inflammatory bowel disease; Medical imaging; Pain; Pediatrics; Polyvinyl alcohol; Spleen; Splenic diseases; Splenic hemangioma; Streptococcus infections; Surgical outcomes; Therapeutic embolization; Tumors; Veins & arteries; South Korea; Japan; Embolization; Child; Splenic hemangioma
• ISSN: 1471-2431; 1471-2431
• DOI: 10.1186/s12887-018-1331-4

Splenic hemangioma is the most common benign tumor of the spleen. However, it remains a rare medical condition in children. Although the natural course of splenic hemangioma is slow growth, treatment for large splenic hemangiomas has been recommended due to the risk of spontaneous rupture causing life-threating hemorrhage. However, the optimal treatment for splenic hemangioma in children is unclear. An 11-year-old girl had an enhancing mass, 61 × 54 × 65 mm in size and numerous daughter nodules throughout the entire spleen on a contrast-enhanced computed tomography scan of the abdomen and angiography. The patient was treated by complete embolization at the distal level of splenic artery, which resulted in total splenic infarction. Treatment-related complications were thrombocytosis and postembolization syndrome, including abdominal pain and, intermittent fever below 39 °C. There were no other serious complications, including bleeding. Splenic embolization may be a safe and less invasive intervention for children with a large splenic hemangioma. Further studies are needed to confirm the effectiveness of our approach.